Benzinga | Aug 4, 2020 07:52AM EDT

Neuronetics Q2 EPS $(0.41) Beats $(0.51) Estimate, Sales $9.70M Beat $8.20M Estimate

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.51) by 19.61 percent. This is a 5.13 percent decrease over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $9.70 million which beat the analyst consensus estimate of $8.20 million by 18.29 percent. This is a 41.47 percent decrease over sales of $16.57 million the same period last year.